| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/10/2000 | WO2000006726A2 Delta-related polypeptides |
| 02/10/2000 | WO2000006717A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 02/10/2000 | WO2000006605A2 Heterominibodies |
| 02/10/2000 | WO2000006195A1 Targeting pharmaceutical agents to injured tissues |
| 02/10/2000 | WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 02/10/2000 | WO1999064603A3 ENHANCEMENT OF B CELL ACTIVATION AND IMMUNOGLOBULIN SECRETION BY CO-STIMULATION OF RECEPTORS FOR ANTIGEN AND EBV Gp350/220 |
| 02/10/2000 | WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 02/10/2000 | WO1999058678A3 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 02/10/2000 | WO1999049039A3 GFRα3 AND ITS USES |
| 02/10/2000 | WO1999042481A3 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF |
| 02/10/2000 | WO1999041376A3 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 02/10/2000 | DE19822823A1 Neue Peptidfragmente zur Reinigung von Proteinen New peptide fragments in protein purification |
| 02/10/2000 | CA2337493A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2337492A1 Delta-related polypeptides |
| 02/10/2000 | CA2337092A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336708A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2336532A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | CA2334170A1 Improved transformation efficiency in phage display through modification of a coat protein |
| 02/09/2000 | EP0977873A1 Method for cleavage of fusion proteins |
| 02/09/2000 | EP0977861A1 Mammalian cytokine-like factor 7 |
| 02/09/2000 | EP0977857A1 Human c-maf compositions and methods of use thereof |
| 02/09/2000 | EP0977852A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/09/2000 | EP0977779A1 Mammalian cytokines; related reagents and methods |
| 02/09/2000 | EP0977583A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 02/09/2000 | EP0531407B1 Analogs of glycoprotein hormones having altered immunological characteristics, efficacy and/or receptor specificity |
| 02/09/2000 | CN1049248C Process for producing exogenous protein with streptomyces |
| 02/08/2000 | US6022960 Nucleotide sequence coding a chimeric gonadotropin releasing hormone; for vaccine development |
| 02/08/2000 | US6022708 Nucleic acid sequence coding human kinase called fused; for detecting modulators of fused kinase activity |
| 02/08/2000 | US6022543 Hepatitis B surface antigen vaccine |
| 02/08/2000 | US6022535 Administering human interleukin-3 variant or mutant proteins (muteins) fused with other colony stimulating factors, cytokines, lyphokines, interleukins, hematopoietic growth factors; treating side effects of cancer radiation therapy |
| 02/03/2000 | WO2000005417A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | WO2000005370A1 Orphan cytokine receptor |
| 02/03/2000 | WO2000005362A1 Mekk1(serine threonine kinases)-interacting fha (forkhead associated domain) protein 1 (mif1) |
| 02/03/2000 | WO2000004926A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 02/03/2000 | WO1999064464A3 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 02/03/2000 | WO1999060120A3 Soluble t cell receptor |
| 02/03/2000 | WO1999060119A3 Multivalent t cell receptor complexes |
| 02/03/2000 | WO1999058571A3 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 02/03/2000 | WO1999051748A3 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 02/03/2000 | CA2335392A1 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 02/03/2000 | CA2334042A1 Orphan cytokine receptor |
| 02/02/2000 | EP0975771A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins |
| 02/02/2000 | EP0975762A1 Type-1 ribosome-inactivating protein |
| 02/02/2000 | EP0975753A2 $g(b)-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME |
| 02/02/2000 | EP0975674A1 Immunotoxins, comprising an onc protein, directed against malignant cells |
| 02/02/2000 | EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA |
| 02/02/2000 | EP0975355A2 Hexameric fusion proteins and uses therefor |
| 02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
| 02/02/2000 | EP0656117B1 A methodology for selecting superagonists, antagonists and superantagonists of interleukin 6 |
| 02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
| 02/01/2000 | US6020212 Phycobiliprotein-linker peptide complex fluorescent tracer and methods of using the same |
| 02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019973 Vaccine against enterotoxin-induced illness. |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 01/27/2000 | WO2000004170A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 01/27/2000 | WO2000004043A1 Protease susceptibility ii |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000003726A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | WO1999061599A3 Recombinant narbonolide polyketide synthase |
| 01/27/2000 | WO1999060127A3 Il-17 homologous polypeptides and therapeutic uses thereof |
| 01/27/2000 | WO1998046257A8 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods |
| 01/27/2000 | CA2613125A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2337231A1 Lysine binding fragments of angiostatin |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/26/2000 | EP0974655A2 G-CSF analog compositions and methods |
| 01/26/2000 | EP0973934A1 Transgenically produced non-secreted proteins |
| 01/26/2000 | EP0973927A1 Chimeric adenoviral coat protein and methods of using same |
| 01/26/2000 | EP0973892A2 28 human secreted proteins |
| 01/26/2000 | EP0973391A1 Endoderm, cardiac and neural inducing factors |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/26/2000 | CN1242376A Human nervous specific expression gene |
| 01/25/2000 | US6018026 For rapid, inexpensive and adaptable high volume screening of ligands to receptors; for determining the presence of cell growth factors in samples; for purifying cell growth factors and isoforms |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
| 01/25/2000 | US6017735 A fusion polypeptide having a herpes virus virion protein and a second protein selected from cell cycle control, suicide protein, antigenic sequences, immunomodulating or therapeutic protein; antiproliferative/anticarcinogenic agents |
| 01/25/2000 | US6017731 Nucleotide sequences encoding a signal sequence, a propeptide leader sequence, a preferred processing site cleaved in situ by a yeast proteolytic enzyme; expressing mammalian proteins and their secretion in a biologically active mature form |
| 01/25/2000 | US6017544 Isolating stress protein-peptide complex from tumor cells previously removed from a mammal and administering the isolated stress protein-peptide complex along with a cytokine to the mammal in order to stimulate an immune response |
| 01/25/2000 | US6017539 Multimeric hybrid genes encoding corresponding chimeric protein comprise gene sequence coding for antigenic region of protein from first pathogen linked to gene sequence coding for antigenic region of protein from second pathogen |
| 01/25/2000 | CA1340879C Recombinant dna product and methods |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO1999059627A3 Verotoxin b subunit for immunization |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/19/2000 | EP0972779A2 Oligonucleotide-polyamide conjugates |
| 01/19/2000 | EP0972055A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0532587B1 Methods for trans-destabilization of specific proteins in vivo |
| 01/19/2000 | EP0515536B1 Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules |
| 01/19/2000 | CN1242043A Receptor ligand VEGF-C |
| 01/18/2000 | US6015938 Osteoprotegerin |
| 01/18/2000 | US6015884 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 01/18/2000 | US6015783 Process for removal or bleaching of soiling or stains from cellulosic fabric |